EE05644B1 - Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG - Google Patents
Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCGInfo
- Publication number
- EE05644B1 EE05644B1 EEP200200469A EEP200200469A EE05644B1 EE 05644 B1 EE05644 B1 EE 05644B1 EE P200200469 A EEP200200469 A EE P200200469A EE P200200469 A EEP200200469 A EE P200200469A EE 05644 B1 EE05644 B1 EE 05644B1
- Authority
- EE
- Estonia
- Prior art keywords
- hcg
- recombinant
- purifying
- purified
- purification
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000011022 Chorionic Gonadotropin Human genes 0.000 abstract 4
- 108010062540 Chorionic Gonadotropin Proteins 0.000 abstract 4
- 229940084986 human chorionic gonadotropin Drugs 0.000 abstract 4
- 238000004255 ion exchange chromatography Methods 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 abstract 1
- 239000000356 contaminant Substances 0.000 abstract 1
- 238000004007 reversed phase HPLC Methods 0.000 abstract 1
- 238000001542 size-exclusion chromatography Methods 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Detergent Compositions (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00103690 | 2000-02-22 | ||
| PCT/EP2001/000665 WO2001062773A1 (en) | 2000-02-22 | 2001-01-22 | PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200200469A EE200200469A (et) | 2004-04-15 |
| EE05644B1 true EE05644B1 (et) | 2013-04-15 |
Family
ID=8167925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200469A EE05644B1 (et) | 2000-02-22 | 2001-01-22 | Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US7297777B2 (no) |
| EP (2) | EP1257564B1 (no) |
| JP (1) | JP4588960B2 (no) |
| KR (1) | KR100806911B1 (no) |
| CN (1) | CN100482679C (no) |
| AT (1) | ATE406378T1 (no) |
| AU (2) | AU783320B2 (no) |
| BG (1) | BG65807B1 (no) |
| BR (1) | BRPI0108556B8 (no) |
| CA (1) | CA2399020A1 (no) |
| CY (1) | CY1108460T1 (no) |
| CZ (1) | CZ303144B6 (no) |
| DE (1) | DE60135541D1 (no) |
| DK (1) | DK1257564T3 (no) |
| EA (1) | EA006605B1 (no) |
| EE (1) | EE05644B1 (no) |
| ES (1) | ES2307585T3 (no) |
| HR (1) | HRP20020650B1 (no) |
| HU (2) | HU228935B1 (no) |
| IL (2) | IL151308A0 (no) |
| ME (1) | ME00296B (no) |
| MX (1) | MXPA02007871A (no) |
| NO (1) | NO328694B1 (no) |
| PL (1) | PL205149B1 (no) |
| PT (1) | PT1257564E (no) |
| RS (1) | RS50741B (no) |
| SI (1) | SI1257564T1 (no) |
| SK (1) | SK287146B6 (no) |
| UA (2) | UA78488C2 (no) |
| WO (1) | WO2001062773A1 (no) |
| ZA (1) | ZA200206109B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE05644B1 (et) * | 2000-02-22 | 2013-04-15 | Applied Research Systems Ars Holding N.V. | Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG |
| EP1709065B1 (en) * | 2004-10-04 | 2010-06-02 | Novetide Ltd. | A counterion exchange process for peptides |
| CN1958603B (zh) * | 2005-11-04 | 2010-05-05 | 上海天伟生物制药有限公司 | 一种人绒毛膜促性腺素的纯化方法 |
| EA200802426A1 (ru) * | 2006-07-11 | 2009-04-28 | Коваль, Антон Александрович | Применение хорионического или лютеинизирующего гормона для профилактики или лечения возрастного гипогонадизма |
| CN101397339B (zh) * | 2008-09-24 | 2012-07-25 | 上海天伟生物制药有限公司 | 糖蛋白中去除/灭活病毒的方法 |
| TWI532495B (zh) | 2009-10-05 | 2016-05-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| CN101792481B (zh) * | 2010-03-12 | 2012-05-30 | 丽珠医药集团股份有限公司 | 一种绒毛膜促性腺激素的纯化方法 |
| WO2012120535A2 (en) * | 2011-02-03 | 2012-09-13 | Sanzyme Limited | A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same |
| CN103619358B (zh) | 2011-03-31 | 2017-02-15 | 辉凌公司 | 药物制剂 |
| WO2013102921A2 (en) * | 2011-11-17 | 2013-07-11 | Sanzyme Limited | Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm) |
| CN103288950A (zh) * | 2012-12-28 | 2013-09-11 | 青岛九龙生物医药有限公司 | 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法 |
| CN104101656A (zh) * | 2013-04-01 | 2014-10-15 | 上海天伟生物制药有限公司 | 一种促性腺激素的纯度测定方法 |
| US20150065426A1 (en) * | 2013-08-27 | 2015-03-05 | Professional Compounding Centers Of America | Testosterone Booster Transdermal Compositions |
| CN105968185A (zh) * | 2016-07-20 | 2016-09-28 | 宁波人健药业集团股份有限公司 | 一种绒促性素纯化方法 |
| CN111233999B (zh) * | 2020-03-21 | 2024-02-23 | 上海浦东明炎生物技术有限公司 | 一种从人尿中提取人绒毛膜促性腺激素的方法 |
| CN113398251B (zh) * | 2021-07-30 | 2022-08-05 | 宁波人健药业集团股份有限公司 | 一种重组人绒毛膜促性腺激素冻干粉针剂及其制备方法 |
| CN116063452A (zh) * | 2023-01-03 | 2023-05-05 | 杭州浦泰生物科技有限公司 | 一种人绒毛膜促性腺激素高效纯化方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3045539B2 (ja) * | 1989-02-21 | 2000-05-29 | ワシントン ユニバーシティ | 改変型生殖ホルモン |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| IT1254370B (it) | 1992-05-22 | 1995-09-14 | Sorin Biomedica Spa | Procedimento per la purificazione di proteine da sistemi cellulari. |
| EP0814841B1 (en) | 1995-03-21 | 2001-12-05 | Applied Research Systems ARS Holding N.V. | Hcg liquid formulations |
| CN1082368C (zh) * | 1995-03-21 | 2002-04-10 | 应用研究系统Ars股份公司 | 人绒毛膜促性腺激素液体制剂 |
| PL187400B1 (pl) * | 1996-02-20 | 2004-06-30 | Applied Research Systems | Białka hybrydowe tworzące heterodimery |
| IT1287138B1 (it) * | 1996-11-07 | 1998-08-04 | Ibsa Inst Biochimique Sa | Procedimento per la separazione e purificazione di fsh e lh |
| AU8142198A (en) | 1997-06-12 | 1998-12-30 | Regents Of The University Of California, The | A transcription factor coactivator protein, p/cip |
| EP0998486B2 (en) * | 1997-06-13 | 2012-02-01 | Genentech, Inc. | Protein recovery by chromatography followed by filtration upon a charged layer |
| US6583109B1 (en) * | 1997-06-24 | 2003-06-24 | Robert C. Gallo | Therapeutic polypeptides from β-hCG and derivatives |
| EE05644B1 (et) * | 2000-02-22 | 2013-04-15 | Applied Research Systems Ars Holding N.V. | Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG |
-
2001
- 2001-01-22 EE EEP200200469A patent/EE05644B1/xx unknown
- 2001-01-22 EP EP01901188A patent/EP1257564B1/en not_active Expired - Lifetime
- 2001-01-22 AU AU26804/01A patent/AU783320B2/en not_active Expired
- 2001-01-22 WO PCT/EP2001/000665 patent/WO2001062773A1/en not_active Ceased
- 2001-01-22 SI SI200130858T patent/SI1257564T1/sl unknown
- 2001-01-22 RS YUP-602/02A patent/RS50741B/sr unknown
- 2001-01-22 HU HU0204231A patent/HU228935B1/hu unknown
- 2001-01-22 BR BRPI0108556A patent/BRPI0108556B8/pt not_active IP Right Cessation
- 2001-01-22 CA CA002399020A patent/CA2399020A1/en not_active Abandoned
- 2001-01-22 PL PL357508A patent/PL205149B1/pl unknown
- 2001-01-22 DE DE60135541T patent/DE60135541D1/de not_active Expired - Lifetime
- 2001-01-22 US US10/204,630 patent/US7297777B2/en not_active Expired - Lifetime
- 2001-01-22 HU HUP1300063 patent/HU1300063D0/hu unknown
- 2001-01-22 JP JP2001562554A patent/JP4588960B2/ja not_active Expired - Lifetime
- 2001-01-22 UA UA2002086890A patent/UA78488C2/uk unknown
- 2001-01-22 SK SK1206-2002A patent/SK287146B6/sk not_active IP Right Cessation
- 2001-01-22 EP EP06024050A patent/EP1752466A3/en not_active Withdrawn
- 2001-01-22 MX MXPA02007871A patent/MXPA02007871A/es active IP Right Grant
- 2001-01-22 EA EA200200892A patent/EA006605B1/ru not_active IP Right Cessation
- 2001-01-22 KR KR1020027010625A patent/KR100806911B1/ko not_active Expired - Lifetime
- 2001-01-22 IL IL15130801A patent/IL151308A0/xx unknown
- 2001-01-22 CN CNB018053637A patent/CN100482679C/zh not_active Expired - Lifetime
- 2001-01-22 DK DK01901188T patent/DK1257564T3/da active
- 2001-01-22 AT AT01901188T patent/ATE406378T1/de active
- 2001-01-22 ME MEP-2008-389A patent/ME00296B/me unknown
- 2001-01-22 PT PT01901188T patent/PT1257564E/pt unknown
- 2001-01-22 CZ CZ20022855A patent/CZ303144B6/cs not_active IP Right Cessation
- 2001-01-22 ES ES01901188T patent/ES2307585T3/es not_active Expired - Lifetime
- 2001-01-22 UA UAA200511832A patent/UA86938C2/uk unknown
- 2001-01-22 HR HR20020650A patent/HRP20020650B1/xx not_active IP Right Cessation
-
2002
- 2002-07-31 ZA ZA200206109A patent/ZA200206109B/en unknown
- 2002-08-14 BG BG107000A patent/BG65807B1/bg unknown
- 2002-08-18 IL IL151308A patent/IL151308A/en active IP Right Grant
- 2002-08-21 NO NO20023985A patent/NO328694B1/no not_active IP Right Cessation
-
2006
- 2006-01-06 AU AU2006200059A patent/AU2006200059A1/en not_active Abandoned
-
2007
- 2007-08-28 US US11/846,118 patent/US20070299001A1/en not_active Abandoned
-
2008
- 2008-10-27 CY CY20081101218T patent/CY1108460T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200200469A (et) | Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG | |
| EE200200464A (et) | Meetod LH puhastamiseks | |
| PL366364A1 (en) | Process for producing peptides by using in vitrotranscription/translation system | |
| CY1107666T1 (el) | Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης | |
| FI913058A0 (fi) | Foerfarande foer behandling av blaoscancerceller. | |
| BR9301641A (pt) | Processo para produzir uma preparacao de fator viii,altamente purificada e uso | |
| ES2161790T3 (es) | Procedimiento de separacion y de purificacion de proteinas dependientes de la vitamina k. | |
| EP0301314A3 (en) | A method for the purification of interferon | |
| Hearn et al. | The Analysis of Insulin-Related Peptides by Reversed-Phase High-Performance Liquid Chromatography | |
| WOMEN | Human chorionic gonadotropine (hCG) is used as a medicinein several diseases like infertility of men and women. This hormone is excreted by urine. At the present time, isolation of hCG from urine is the only way for preparation of this hormone. The highest concentration of hCG in urine and serum is in the early second trimester of pregnancy. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB1A | Change in the ownership or in the address of the owner | ||
| HC1A | Change of owner name |